Solanezumab was safe and well-tolerated for Asian patients...

Solanezumab was safe and well-tolerated for Asian patients with mild-to-moderate Alzheimer's disease in a multicenter, randomized, open-label, multi-dose study

Taro Goto, Shinji Fujikoshi, Kazunori Uenaka, Shinichi Nishiuma, Eric R. Siemers, Robert A. Dean, Michihiro Takahashi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2010
Language:
english
DOI:
10.1016/j.jalz.2010.05.1003
File:
PDF, 45 KB
english, 2010
Conversion to is in progress
Conversion to is failed